Search our Database of Scientific Publications and Authors

I’m looking for a
    Effects of ICOS+ T cell depletion via afucosylated monoclonal antibody MEDI-570 on pregnant cynomolgus monkeys and the developing offspring.
    Reprod Toxicol 2017 Dec 13;74:116-133. Epub 2017 Sep 13.
    Toxicology, Research & Development, MedImmune Inc., One MedImmune Way, Gaithersburg, MD 20854, United States.
    MEDI-570 is a fully human afucosylated monoclonal antibody (MAb) against Inducible T-cell costimulator (ICOS), highly expressed on CD4+ T follicular helper (TFH) cells. Effects of MEDI-570 were evaluated in an enhanced pre-postnatal development toxicity (ePPND) study in cynomolgus monkeys. Administration to pregnant monkeys did not cause any abortifacient effects. Changes in hematology and peripheral blood T lymphocyte subsets in maternal animals and infants and the attenuated infant IgG immune response to keyhole limpet hemocyanin (KLH) were attributed to MEDI-570 pharmacology. Adverse findings included aggressive fibromatosis in one dam and two infant losses in the high dose group with anatomic pathology findings suggestive of atypical lymphoid hyperplasia. The margin of safety relative to the no observed adverse effect level (NOAEL) for the highest planned clinical dose in the Phase 1a study was 7. This study suggests that women of child bearing potential employ effective methods of contraception while being treated with MEDI-570.

    Similar Publications

    An Enhanced Pre- and Postnatal Development Study in Cynomolgus Monkeys with Tabalumab: A Human IgG4 Monoclonal Antibody.
    Birth Defects Res B Dev Reprod Toxicol 2015 Jun 20;104(3):100-16. Epub 2015 Jul 20.
    Charles River Laboratories, Reno, Nevada.
    Tabalumab, a human IgG4 monoclonal antibody (mAb) with neutralizing activity against both soluble and membrane B-cell activating factor (BAFF), has been under development for the treatment of autoimmune diseases. The purpose of this study was to determine the potential adverse effects of maternal tabalumab exposure on pregnancy, parturition, and lactation of the mothers and on the growth, viability, and development of the offspring through postnatal day (PND) 204. Tabalumab was administered by subcutaneous injection to presumed pregnant cynomolgus monkeys (16-19 per group) every 2 weeks from gestation day (GD) 20 to 22 until parturition at doses of 0, 0. Read More
    T-cell-dependent antibody response: assay development in cynomolgus monkeys.
    J Immunotoxicol 2005 Oct;2(4):191-6
    Worldwide Safety Sciences, Pfizer Global Research and Development, Ann Arbor, Michigan 48105, USA.
    The current study was designed to develop and test a T-cell dependent antibody response to keyhole limpet hemocyanin (KLH) in cynomolgus monkeys. In an optimization experiment, monkeys (3/sex) were given a single intramuscular injection of KLH at 10 mg/animal to evaluate the kinetics of the antibody response. Serum samples were collected pretest, and on Days 4, 6, 8, 11, 15 and 22 for measurement of anti-KLH IgM and IgG endpoint titers. Read More
    Fully human anti-BAFF inhibitory monoclonal antibody tabalumab does not adversely affect T-dependent antibody responses in cynomolgus monkey (Macaca fasicularis): A summary of three pre-clinical immunotoxicology evaluations.
    J Immunotoxicol 2016 4;13(1):7-19. Epub 2015 Sep 4.
    c Wierda Toxicology Consulting, Inc. , New Palestine , IN , USA.
    The potential immunotoxicity of tabalumab was assessed as a component of standard pre-clinical toxicology studies in cynomolgus monkeys. To evaluate potential tabalumab-associated immunosuppression after antigen challenge, cynomolgus monkeys were administered placebo control or tabalumab in three immunotoxicological safety studies. Study 1, a 4-week pilot study, evaluated biweekly intravenous (IV) control, and 0. Read More
    Characterization of the adaptive immune response following immunization in pregnant sows (Sus scrofa) kept in two different housing systems.
    J Anim Sci 2014 Aug 19;92(8):3388-97. Epub 2014 Jun 19.
    Department of Behavioral Physiology of Farm Animals, Institute of Animal Husbandry and Animal Breeding, University of Hohenheim, 70599 Stuttgart, Germany.
    Housing conditions might differentially affect the adaptive immune responses to a neoantigen in pregnant sows with possible consequences for the success of vaccinations. Therefore, this study aimed at characterizing antigen-specific T cell and B cell responses of pregnant sows (German Landrace) either housed in a social group (GP; n = 22) or confined in individual gestation crates (CR; n = 11). All sows were immunized with the neoantigen keyhole limpet hemocyanin (KLH) 7 and 5 wk prepartum. Read More